Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for cognitive impairment from sleep deprivation
NCT00800553Phase 4Completed
- Sponsor
- Duke-NUS Medical School
- Start
- Nov 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil in cognitive impairment (2 arms), sponsored by Duke-NUS Medical School. Primary endpoints: fMRI signal change in response to cholinergic augmentation within the context of sleep deprivation and behavioral changes (response accuracy in a visual short term memory task). Started Nov 2006; status: completed.
02
Drugs
donepezil
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT00800553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00800553.